QuantaMatrix
QuantaMatrix Inc. is a leading in-vitro diagnostics company founded in 2010, specializing in microbiology, molecular biology, and immunoassay solutions. The company focuses on innovative platforms such as rapid antimicrobial susceptibility testing (dRAST), early detection of Alzheimer's disease, and prognostic kits for cardiovascular diseases. Its mission is to save lives, improve patient health, reduce healthcare costs, and fight antimicrobial resistance through cutting-edge diagnostic solutions.
Industries
Nr. of Employees
medium (51-250)
Patents
Rapid cell culture test device designed such that fluid films with uniform thickness are formed
US-12297482-B2
View DetailsMulti-well-based cell culture test device for rapid antibiotic susceptibility testing
US-11377679-B2
View DetailsRapid antimicrobial susceptibility test, based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and automated cell image analysis system therefor
US-10947575-B2
View DetailsRapid antibiotic susceptibility testing system based on bacterial immobilization using gelling agent, antibiotic diffusion and tracking of single bacterial cells
US-10676776-B2
View Details
Rapid cell culture test device designed such that fluid films with uniform thickness are formed
US-12297482-B2
View DetailsMulti-well-based cell culture test device for rapid antibiotic susceptibility testing
US-11377679-B2
View DetailsRapid antimicrobial susceptibility test, based on an analysis of changes in morphology and growth pattern of a microbial cell under different concentrations of various antimicrobial agents, and automated cell image analysis system therefor
US-10947575-B2
View DetailsRapid antibiotic susceptibility testing system based on bacterial immobilization using gelling agent, antibiotic diffusion and tracking of single bacterial cells
US-10676776-B2
View DetailsProducts
Rapid direct antimicrobial susceptibility test (blood-culture to MIC)
An in-vitro diagnostic system that performs direct phenotypic susceptibility testing from positive blood cultures and reports MIC-based results in ~4 hours using microfluidics, agarose immobilization and time-lapse microscopy.
Blood-based multi-marker Alzheimer's disease assay
A plasma-based multiplex immunoassay for early detection/prediction of Alzheimer's disease by measuring multiple blood biomarkers and applying an algorithm to infer pathological amyloid beta accumulation.
Rapid tuberculosis drug susceptibility test
A rapid drug susceptibility assay for Mycobacterium tuberculosis designed to reduce time to drug susceptibility results for tuberculosis management.
Cardiovascular prognostic biomarker panels
Multiplex biomarker panels intended to predict early heart failure risk and prognosis after acute myocardial infarction using novel biomarker candidates.
QPLEX Alz plus assay
A non-invasive and low-cost diagnostic kit for Alzheimer's disease that detects multiple Alzheimer's disease biomarkers from patient plasma using the QMAP platform and a proprietary algorithm to predict early Alzheimer's disease.
dRAST
dRAST provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture in as low as 4 hours, reducing time to results by up to 2 days compared to conventional methods.
Rapid direct antimicrobial susceptibility test (blood-culture to MIC)
An in-vitro diagnostic system that performs direct phenotypic susceptibility testing from positive blood cultures and reports MIC-based results in ~4 hours using microfluidics, agarose immobilization and time-lapse microscopy.
Blood-based multi-marker Alzheimer's disease assay
A plasma-based multiplex immunoassay for early detection/prediction of Alzheimer's disease by measuring multiple blood biomarkers and applying an algorithm to infer pathological amyloid beta accumulation.
Rapid tuberculosis drug susceptibility test
A rapid drug susceptibility assay for Mycobacterium tuberculosis designed to reduce time to drug susceptibility results for tuberculosis management.
Cardiovascular prognostic biomarker panels
Multiplex biomarker panels intended to predict early heart failure risk and prognosis after acute myocardial infarction using novel biomarker candidates.
QPLEX Alz plus assay
A non-invasive and low-cost diagnostic kit for Alzheimer's disease that detects multiple Alzheimer's disease biomarkers from patient plasma using the QMAP platform and a proprietary algorithm to predict early Alzheimer's disease.
dRAST
dRAST provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture in as low as 4 hours, reducing time to results by up to 2 days compared to conventional methods.
Services
Maintenance of a commercial distribution network and regional contact support for product information and distribution.
Provision of material safety data sheets and technical files for diagnostic reagent kits and panels.
Maintenance of a commercial distribution network and regional contact support for product information and distribution.
Provision of material safety data sheets and technical files for diagnostic reagent kits and panels.
Expertise Areas
- Rapid antimicrobial susceptibility testing (phenotypic)
- Clinical microbiology diagnostics
- Microfluidic assay design and implementation
- Time-lapse microscopy and image-based analysis
Key Technologies
- Microfluidics
- Time-lapse microscopic imaging
- Phenotypic MIC-based AST
- Dried reagent/antibiotic panels
News & Updates
News & Events update on January 7, 2025.
Update on the land site '대지 7'.
Update on the land site '대지 9'.
Equipment maintenance checklist update.
Internal information management regulation announcement.
Land site '대지-8-3' update.
News & Events update on January 7, 2025.
Update on the land site '대지 7'.
Update on the land site '대지 9'.
Equipment maintenance checklist update.
Internal information management regulation announcement.
Land site '대지-8-3' update.